Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “air”

656 pharma patents match "air" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 656
Index total 30,257
Page 14 / 28

Quick answer

This filtered view shows 656 pharmaceutical patents matching "air" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

656 results for “air” · 30,257 patents in full index Clear search

  1. US 10357522

    Bacteriophage compositions and methods of selection of components against specific bacteria

    United States of America as represented by the Secretary of the Air Force · Granted Jul 23, 2019 · Expires Jul 18, 2039

    granted

  2. US 10344061

    Peptide exhibiting hair growth promoting activity and/or melanin production promoting activity and use thereof

    CAREGEN CO., LTD. · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  3. US 10335365

    Bladder cancer specific ligand peptides

    The United States of America as represented by the Department of Veteran Affairs (Washington DC) · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  4. US 10322125

    TGF-beta enhancing compositions for cartilage repair and methods related thereto

    The United States of America as represented by the Department of Veteran Affairs · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted

  5. US 10322161

    EPHA4 cyclic peptide antagonists for neuroprotection and neural repair

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted

  6. US 10322124

    6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases

    Sulfateq B.V. · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted

  7. US 10307388

    Compositions and methods for diagnosis and treatment of inflammation

    United States of America as represented by the Secretary of the Air Force · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  8. US 10307423

    FBXO3 inhibitors

    United States Government as represented by the Department of Veterans Affairs · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  9. US 10286054

    Attenuated EHEC and clostridial toxins TcdA and TcdB based vaccine for Clostridium difficil associated disease (CDAD)

    United States Government as represented by the Department of Veterans Affairs · Granted May 14, 2019 · Expires May 9, 2039

    granted

  10. US 10285935

    Non-invasive method for direct delivery of therapeutics to the spinal cord in the treatment of spinal cord pathology

    United States Department of Veteran Affairs · Granted May 14, 2019 · Expires May 9, 2039

    granted

  11. US 10272163

    Factor VIII mutation repair and tolerance induction

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  12. US 10265372

    Molecular composition for enhancing and rejuvenating maintenance and repair of mammalian tissues

    The Regents of the University of California · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  13. US 10251977

    Compositions and methods for tissue repair with extracellular matrices

    The Regents of the University of California · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  14. US 10246514

    Single domain antibodies that bind to human CD20

    United States of America as represented by the Secretary of the Air Force · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted

  15. US 10238710

    Peptide having anti-inflammatory, osteogenic and hair growth promoting activities, and use of same

    CAREGEN CO., LTD. · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  16. US 10238618

    Compositions and methods for diagnosis and treatment of anemia

    United States of America as represented by the Secretary of the Air Force · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  17. CA 3075215

    INHIBITEUR DE L'HISTONE DESACETYLASE EN ASSOCIATION AVEC UN MODULATEUR DE POINT DE CONTROLE IMMUNITAIRE POUR LA CANCEROTHERAPIE

    4SC AG [DE] · Granted Mar 14, 2019 · Expires Mar 9, 2039

    granted

  18. US 10202584

    Red-shifted luciferase-luciferin pairs for enhanced bioluminescence

    The Regents of the University of California · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  19. US 10202631

    Multi-tiered, high through-put screen for compounds effective against bacterial biofilm compounds effective for inhibiting and eradicating bacterial biofilm

    United States of America as represented by the Secretary of the Air Force · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  20. US 10196612

    Method of characterizing and manipulating adipose stem cell depots to a metabolically healthy state

    The United States of America as Represented by the Department of Veterens Affairs · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  21. US 10189878

    Ebolavirus pre-hairpin intermediate mimics and methods of use

    The United States of America—Air Force · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted

  22. US 10166244

    Targeting NCCA-ATP channel for organ protection following ischemic episode

    The United States of America as represented by the Department of Veteran Affairs · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  23. US 10166271

    Methods for promoting hair growth

    The Regents of the University of California · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  24. US 10166277

    Vault immunotherapy

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.